Monday, January 30, 2023

Here’s My Top Value Stock to Buy Right Now By StockNews


© Reuters. Here’s My Top Value Stock to Buy Right Now

With stocks hitting new highs again today, it’s always nice to find a stock that isn’t overvalued. Exelixis, Inc. (NASDAQ:) is one such stock. The company’s lead molecule, cabozantinib, offers treatment for numerous indications, which makes this an intriguing pick. Investors looking for value stocks should take notice.Exelixis, Inc. (EXEL) is a biopharmaceutical firm that discovers, develops, and commercializes cancer treatments. Its lead molecule cabozantinib is indicated for the treatment of patients with metastatic medullary thyroid cancer and advanced renal cell carcinoma. It is also approved for kidney cancer, hepatocellular carcinoma, and liver cancer.

Cabozantinib has been a big money maker. For instance, the uptake of Cabometyx, a tablet formulation of cabozantinib, to treat patients with advanced renal cell carcinoma who have received prior anti-angiogenic therapy, has been very strong.

The drug’s label was also expanded to treat previously-untreated, advanced renal cell carcinoma. This has significantly boosted demand for the drug. In fact, kidney cancer is one of the most commonly diagnosed forms of cancer in both men and women, and renal cell carcinoma is the most common form of kidney cancer in adults.

Continue reading on StockNews

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Source link


Please enter your comment!
Please enter your name here



Related Stories